Welcome to our dedicated page for Elevance Health news (Ticker: ELV), a resource for investors and traders seeking the latest updates and insights on Elevance Health stock.
Elevance Health, Inc. (NYSE: ELV) generates a steady stream of news as a major participant in the direct health and medical insurance carriers industry. Company updates frequently focus on financial performance, member experience initiatives, digital tools, and community health programs. Investors and observers following ELV news can see how Elevance Health communicates its strategy as a lifetime, trusted health partner serving over 109 million consumers through medical, pharmacy, behavioral, clinical, home health, and complex care solutions.
News coverage often includes earnings results and guidance, such as quarterly financial releases that detail segment performance for Health Benefits and Carelon, membership trends across commercial, Medicare, Medicaid, and Federal Employee Program lines, and commentary on benefit expense ratios and operating metrics. The company also issues announcements about upcoming conference calls and webcasts where management reviews results and outlook with investors.
Another key theme in Elevance Health news is the evolution of the healthcare consumer experience. Articles describe AI-enabled digital solutions, including the Virtual Assistant available through the Sydney Health app, which helps members understand benefits, compare costs, and find in-network providers. The company also highlights care management programs, concierge-style support for serious illnesses, and models such as “My Health Advocate” in affiliated Medicare plans.
Elevance Health news frequently covers whole-health and community initiatives. Examples include Food as Medicine partnerships with the National Association of Community Health Centers, school-based fitness facility upgrades, and expanded access to doula care and social supports in certain Medicare Advantage and Medicaid plans. Governance developments, such as the appointment of independent directors to the board and related committee assignments, are also reported through press releases and SEC-linked announcements.
By reviewing the ELV news feed on this page, readers can follow financial disclosures, strategic initiatives, digital and clinical innovations, and community-focused programs that shape Elevance Health’s role in the health benefits and healthcare services landscape.
AM Best has affirmed the Financial Strength Rating (FSR) of A- (Excellent) and a Long-Term Issuer Credit Rating of 'a-' (Excellent) for
Elevance Health released a study indicating that individuals experiencing long COVID face significantly higher risks for various adverse cardiovascular and pulmonary conditions, as well as increased mortality rates compared to those without COVID-19.
The study, the largest of its kind involving 13,435 long COVID patients, highlights that:
- 2.35 times more likely to experience cardiac arrhythmias
- 3.64 times more likely to face pulmonary embolism
- 2.8% mortality rate in long COVID patients versus 1.2% in non-COVID patients
This highlights a need for better care management programs to address these risks.
Elevance Health (NYSE: ELV) has finalized its acquisition of BioPlus, a notable specialty pharmacy, enhancing its capabilities in managing complex health conditions. This strategic move focuses on providing comprehensive pharmacy services across all 50 states, particularly for patients with chronic ailments like cancer and multiple sclerosis. The integration of BioPlus into Elevance’s CarelonRx will enable improved accessibility and affordability of specialty drugs, aiming to elevate patient care and experience. Elevance plans to expand BioPlus’ service models, aligning with its commitment to holistic healthcare solutions.
Elevance Health, Inc. (NYSE: ELV) announced that from October 15, 2022, its 2.750% Senior Convertible Debentures due 2042 will accrue a contingent interest of 0.50% per annum based on the average trading price over the preceding ten days. This translates to approximately $16.8123 per Note, payable on April 15, 2023, to record holders as of April 1, 2023. The company serves over 119 million individuals through various healthcare services, emphasizing its commitment to improving health outcomes.
Elevance Health reported strong financial results for Q4 and the full year 2022, with GAAP net income of $3.93 and $24.81 per share, respectively. Adjusted net income was $5.23 and $29.07 per share. Operating revenue increased 13.7% year-over-year to $156 billion, and operating gain grew 12.9% to $8.5 billion. Medical enrollment rose by 2.2 million members to 47.5 million. A quarterly dividend increased by 16% to $1.48 per share. For 2023, the company anticipates GAAP net income exceeding $29.80 per share. These results reflect Elevance’s progress towards becoming a trusted health partner, with strategic advances to optimize their businesses.
AM Best has confirmed that the Credit Ratings of Elevance Health (NYSE: ELV) and its subsidiaries remain unchanged after the announcement on
Elevance Health has announced a definitive agreement to acquire Blue Cross and Blue Shield of Louisiana (BCBSLA). This acquisition aims to enhance community health services, leveraging Elevance's advanced healthcare capabilities. BCBSLA, serving over 1.9 million members, will continue to operate from Baton Rouge and maintain its local workforce of approximately 3,000 employees. The deal, expected to close later this year, will also establish the Accelerate Louisiana Initiative, a multibillion-dollar foundation focused on health equity. The acquisition is subject to customary closing conditions and regulatory approvals.
Elevance Health (NYSE: ELV) is set to release its fourth quarter 2022 financial results on January 25, 2023, at 6:00 a.m. EST. A conference call will follow at 8:30 a.m. EST, where management will discuss the results and future outlook. Interested participants should access the call 15 minutes early, using specific phone numbers for domestic and international calls. The call will also be available via a live webcast on Elevance Health's website.
Elevance Health (NYSE: ELV) has earned full three-year accreditation for health equity from the National Committee for Quality Assurance (NCQA) for 21 of its affiliated Medicaid plans. This accreditation highlights the company's commitment to enhancing health equity and addressing the needs of historically marginalized communities. Currently, 93% of Elevance Health's Medicaid members are enrolled in accredited plans, representing a significant achievement in the industry. The company aims to innovate and improve care for diverse populations across the nation.
Elevance Health has partnered with Impact Fitness Foundation to enhance the fitness resources at Herron-Riverside High School in
The upgraded facility, unveiled on
FAQ
What is the current stock price of Elevance Health (ELV)?
What is the market cap of Elevance Health (ELV)?
